Companies / Rapport Therapeutics, Inc. / Transactions
Back to Rapport Therapeutics, Inc.

Rapport Therapeutics, Inc.

All insider transactions

20 transactions

Date ↓MoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Mar 30, 2026SellCommon StockGault Cheryl
Executive
-2,839$28.55$81.1K159,914low
Mar 30, 2026SellCommon StockGault Cheryl
Executive
-7,161$28.04$200.8K162,753medium
Mar 25, 2026Sell
ⓘ
Common StockYeleswaram Krishnaswamy
Executive
-10,115$29.99$303.4K286,876medium
Mar 5, 2026SellCommon StockGault Cheryl
Executive
-2,014$28.93$58.3K169,914low
Feb 19, 2026Other
Option exercise
Common StockBredt David
Executive
+6,000$1.80$10.8K393,075low
Feb 18, 2026SellCommon StockCeesay Abraham
CEO
-2,100$29.80$62.6K20,729low
Feb 18, 2026SellCommon StockCeesay Abraham
CEO
-2,983$29.04$86.6K22,829low
Feb 18, 2026SellCommon StockCeesay Abraham
CEO
-2,281$29.80$68.0K556,247low
Feb 18, 2026SellCommon StockCeesay Abraham
CEO
-3,552$29.05$103.2K558,528medium
Feb 17, 2026Sell
ⓘ
Common StockBredt David
Executive
-2,200$29.59$65.1K387,075low
Feb 17, 2026Sell
ⓘ
Common StockBredt David
Executive
-5,400$28.95$156.3K389,275medium
Feb 17, 2026Sell
ⓘ
Common StockBredt David
Executive
-900$28.02$25.2K394,675low
Jan 20, 2026SellCommon StockCeesay Abraham
CEO
-5,083$26.11$132.7K25,812medium
Jan 20, 2026SellCommon StockCeesay Abraham
CEO
-5,833$26.12$152.3K562,080medium
Jan 15, 2026SellCommon StockBredt David
Executive
-200$27.40$5.5K395,575low
Jan 15, 2026Sell
ⓘ
Common StockBredt David
Executive
-8,300$26.83$222.7K395,775medium
Dec 31, 2025SellCommon StockBredt David
Executive
-6,567$30.05$197.3K404,075medium
Dec 31, 2025Other
Grant / award
Common StockBredt David
Executive
-18,000——410,642low
Dec 31, 2025SellCommon StockYeleswaram Krishnaswamy
Executive
-2,840$30.05$85.3K296,991low
Dec 31, 2025Other
Grant / award
Common StockYeleswaram Krishnaswamy
Executive
+9,000——299,831low
← PrevPage 1 of 1Next →